Autoregulation of Glomerular Filtration Rate in Patients With Type 1 Diabetes During Spironolactone Therapy
NCT00335413 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 17
Last updated 2008-06-05
Summary
To evaluate the impact of spironolactone treatment on renal autoregulation in hypertensive type 1 diabetic patients.
Conditions
Interventions
- DRUG
-
Spironolactone
Sponsors & Collaborators
-
Steno Diabetes Center Copenhagen
lead OTHER
Principal Investigators
-
Hans-Henrik Parving, MD,DMSc,Prof · Steno Diabetes Center Copenhagen
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-06-30
- Completion
- 2007-04-30
More Related Trials
-
Mineralocorticoid Antagonism and Endothelial Dysfunction in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
NCT01853553 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Spironolactone on Calcineurin Inhibitor Induced Nephrotoxicity
NCT01602861 ·Status: COMPLETED ·Phase: PHASE4
-
Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease
NCT06190158 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Cardiovascular Protective Effect of Spironolactone in Hemodialysis
NCT00277693 ·Status: UNKNOWN ·Phase: PHASE4
-
Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria
NCT02040441 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Examining the Effect of Different Diuretics on Fluid Retention in Diabetics Treated With Rosiglitazone.
NCT00306696 ·Status: COMPLETED ·Phase: PHASE4
-
Hemodynamic Effects of Spironolactone in Patients With Heart Failure
NCT00860340 ·Status: COMPLETED ·Phase: NA
-
Effects of Spironolactone Combination Therapy on Proteinuria, Kidney Function, and Blood Pressure
NCT01667614 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study of Aprepitant Effect on Aldosterone Secretion in Diabetic Patient (Diabetes Mellitus) With Hypertension Associated With Low Renin
NCT02811055 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Spironolactone on Cardio- and Cerebrovascular Morbidity and Mortality in Hemodialysis Patients
NCT01687699 ·Status: COMPLETED ·Phase: PHASE4
-
Spironolactone and Insulin Resistance in Chronic Heart Failure (CHF)
NCT00664222 ·Status: COMPLETED ·Phase: PHASE4
-
Spironolactone Safety in Dialysis Patients
NCT00328809 ·Status: WITHDRAWN ·Phase: PHASE4
-
The Effect in Renal Function on Patients With Type 1 Cardiorenal Syndrome Treated With Two Strategies of Furosemide.
NCT04393493 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Spironolactone on Acute Kidney Injury in Patients Undergoing Coronary Angiography
NCT03329443 ·Status: COMPLETED ·Phase: PHASE2
-
Role of Mineralocorticoid Receptor in Diabetic Cardiovascular Disease
NCT00865124 ·Status: COMPLETED ·Phase: NA
-
The Effect of Amiloride and Spironolactone in Healthy Persons
NCT00857909 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Spironolactone in Dialysis
NCT01128101 ·Status: UNKNOWN ·Phase: PHASE4
-
Spironolactone in Patients With Single Ventricle Heart
NCT00211081 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Spironolactone in Cameroonian Diabetic Patients With Resistant Hypertension
NCT02426099 ·Status: COMPLETED ·Phase: PHASE4
-
Importance of Aldosterone in the Pathogenesis of Hypertensive Heart Disease
NCT00865501 ·Status: COMPLETED ·Phase: PHASE3
-
The Role of Aldosterone in Circulatory Disorders Within Type 2 Diabetes
NCT03017703 ·Status: COMPLETED ·Phase: NA
-
Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease
NCT03020303 ·Status: COMPLETED ·Phase: PHASE3
-
The Effects of Amiloride and Spironolactone on Renophysiological and Cardiovascular Variables
NCT01195805 ·Status: COMPLETED ·Phase: NA
-
Spironolactone in CKD Enabled by Chlorthalidone: PILOT
NCT05222191 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy of Candesartan on Symptomatic Heart Failure in Treating Diabetic and Hypertensive Patients.
NCT00775840 ·Status: COMPLETED ·Phase: PHASE3